PDS Planning, Inc - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDS Planning, Inc ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2024$146,581
-16.2%
10,553
-6.7%
0.02%
-34.8%
Q3 2023$174,997
+1.4%
11,312
+2.9%
0.02%
+4.5%
Q2 2023$172,637
-5.1%
10,989
-0.5%
0.02%
-12.0%
Q1 2023$181,92311,0390.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders